Home › Lung Cancer › Colorado › Denver
Lung Cancer clinical trials in Denver, CO
16 studies for Lung Cancer are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Kaiser Permanente-Franklin, Denver
- National Jewish Health-Main Campus, Denver
- Rocky Mountain Cancer Centers - Swedish, Englewood · 6 mi away
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Kaiser Permanente-Franklin, Denver
- Rocky Mountain Cancer Centers - Swedish, Englewood · 6 mi away
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Kaiser Permanente-Franklin, Denver
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RecruitingPhase 1
- Presbyterian/St Lukes Medical Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- Rocky Mountain Cancer Center, Denver
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Sarah Cannon Research Institute at HealthOne, Denver
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, Denver
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Kaiser Permanente-Franklin, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- AdventHealth Porter, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RecruitingPhase 1
- Sarah Cannon Research Institute - Denver DDU, Denver
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- UCHealth - Cherry Creek, Denver
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RecruitingPhase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RecruitingPhase 1
- Sarah Cannon, SCRI Oncology Partners - Health One, Denver
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RecruitingPhase 1/2
- Sarah Cannon Research Institute Denver, Denver
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Denver
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Arlington, VA40 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)19 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
- Pancreatic Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.